Medical Advocates
Nevirapine (Viramune)
 
National PMTCT Studies

Africa
 Asia
Europe
 Latin America/Caribbean






 
NVP  Main Page  Main New/Newsworthy

Home Page

  

 

  
Last Update:  April 09, 2008
 Documents identified with this icon are in Portable Document Format (PDF) and require the Adobe Acrobat Reader
Asia
 
India

          Conference Reports, Abstracts, and Posters
 

 
Extended-dose Nevirapine to 6 Weeks of Age for Infants in Ethiopia, India, and Uganda: A
Randomized Trial for Prevention of HIV Transmission through Breastfeeding
 J Sastry and The Six Week Extended Dose Nevirapine Study Team
(15th CROI)
 Abstract
 
Elimination kinetics of single 200 mg dose of oral nevirapine in HIV-1-infected pregnant Indian
women
Mhatre R.B., Thakur P.A., Dalvi S, et al
 (XVI International AIDS Conference)
 Abstract

Challenges encountered in administering the second dose Nevirapine to the infants born
to HIV positive women in Namakkal PMTCT Project, India
J J Vijayakumari, J Sara Mini, N M Samuel
 (15IAC)
 Abstract

SAFETY AND IMMUNOLOGICAL EFFECTIVENESS OF SIMPLIFIED FIXED DOSE
COMBINATION OF NEVIRAPINE BASED HAART AMONGST INDIAN PATIENTS:
EXTENDED FOLLOW-UP DATA
S. Pujari, A. Patel, E. Naik, et al
 (2nd IAS)
 Abstract
 
Nevirapine in Unregistered Seropositive mothers at Namakkal Government Hospital - in
South India
S Parameshwari, M Jacob, R Viswanath,  et al
 (14IAC)
 Abstract
 
Thailand

          Journal Papers, Abstracts, and Commentaries
 
  Nevirapine-associated toxicity in HIV-infected Thai men and women, including pregnant
women.
Phanuphak N, Apornpong T, Teeratakulpisarn S, et al
HIV Med. 2007 Sep;8(6):357-66.
 Abstract

          Conference Reports, Abstracts, and Posters
 

 
24 month outcome of nevirapine based highly active antiretroviral therapy (HAART) in women
during the postpartum period: a PMTCT+ pilot program supported by the global fund in Thailand
 Jourdain G., Briand N., Fregonese F  
(XVI International AIDS Conference)
 Abstract

Duration of nevirapine (NVP) postpartum exposure in women who received single
dose NVP during labor in addition to standard zidovudine (ZDV) prophylaxis for the
prevention of mother-to-child transmission of HIV-1 in Thailand
T R Cressey, S Kunkeaw, P N Ruttana-Aroongorn., et al
 (15IAC)
 Abstract

Infant ARV prophylaxis failures from a study of a short-course zidovudine plus 2-dose
nevirapine regimenfor prevention of mother-to-child HIV transmission in Thailand
N Vanprapar, T Chotpitayasunondh, M Culnane, et al
 (15IAC)
 Abstract 
 
PHPT-2: Nevirapine Plus Zidovudine For The Prevention Of Perinatal HIV
M  Lallemant, V Thaineua, G Jourdain
 (14IAC)
 Abstract
 
Nevirapine (NVP) during labor and in the neonate significantly improves zidovudine (ZDV)
prophylaxis for the prevention of perinatal HIV transmission: results of PHPT-2 first interim
analysis
M Lallemant, G Jourdain, S Le Coeur, et al
 (14IAC)
 Abstract
Australia/Pacific Islands
 
Europe
 
Germany

          Conference Reports, Abstracts, and Posters

  Therapeutic drug monitoring (TDM) of nevirapine in HIV-infected pregnant women of the
Frankfurt HIV Cohort
A Haberl, M Kurowski, S Staszewski
 (14IAC)
 Abstract
 
Ireland

          Conference Reports, Abstracts, and Posters
 
  NEVIRAPINE TOLERABILITY IN HIV INFECTED WOMEN IN PREGNANCY -
A WORD OF CAUTION 
F. Lyons, S. Hopkins, A. Mc Geary, et al
 (2nd IAS)
 Abstract
Latin America/Caribbean
 
Argentina

           Journal Papers, Abstracts, and Commentaries
 
 
Low rate of emergence of nevirapine and lamivudine resistance after post-partum interruption of a
triple-drug regimen.
 Pérez H, Vignoles M, Laufer N, et al
Antivir Ther. 2008;13(1):135-9.
 Abstract

Nevirapine toxicity in a cohort of HIV-1-infected pregnant women.
 Joao EC, Calvet GA, Menezes JA, et al   
Am J Obstet Gynecol. 2006 Jan;194(1):199-202
 Abstract
 
Brazil
 
          Journal Papers, Abstracts, and Commentaries
 
  Nevirapine-induced side effects in pregnant women: experience of a Brazilian university
hospital.
Kondo W, Carraro EA, Prandel E, et al
 Braz J Infect Dis. 2007 Dec;11(6):544-8.
 Abstract

          Conference Reports, Abstracts, and Posters
 
  Adverse reactions related to antiretroviral regimen containing nevirapine used by HIV-infected
pregnant women from the maternal and perinatal cohort of Belo Horizonte, Brazil
Aguiar R.A.L.P., Melo V.H., Cavallo I.K.D., et al
 (XVI International AIDS Conference)
 Abstract
 
Barbados

          Conference Reports, Abstracts, and Posters
 

 		 Reduction of perinatal transmission of HIV after treatment with Nevirapine
MA St John
 (15IAC)
 Abstract
 
Dominican Republic

          Conference Reports, Abstracts, and Posters
 

 
Cost of multi-dose antiretroviral (ARV) versus single-dose nevirapine treatment for prevention
of mother-to-child HIV transmission (pMTCT) in the Dominican Republic (DR): potential
savings associated with greater efficacy
Roman-Pouriet J., Kley N., Fernandez A.D., et al
 (XVI International AIDS Conference)
 Abstract

The provision of nevirapine for the prevention of mother-to-child transmission of human
immunodeficiency virus in Puerto Plata, Dominican Republic
LE Galpin, P Tebas, B Gomez, et al
 (15IAC)
 Abstract
 

Nevirapine: An affordable and effective option for preventing Mother-to-Child
transmission of HIV in developing countries
 E Cruz, R Pena, F Garcia, M Goyanes, et al
 (14IAC)
 Abstract
Middle East
 
North America
 
Russia/NIS
 

Ukraine

          Conference Reports, Abstracts, and Posters
  Successful nevirapine-based prevention of mother-to-child transmission in Southern Ukraine
B W van der Meer, K Lezhentsev, et al
 (15IAC)
 Abstract

NVP  Main Page  Main New/Newsworthy

Home Page

  

 

  

 National Nevirapine PMTCT Studies